Learning Objectives:
- To describe the role of the ANA (antinuclear antibody) testing in the new ACR/EULAR classification criteria
- To describe the technologies used to assess ANA levels
- To describe strategies for optimal use of ANA testing in the clinical setting
Disclosures: None
CME Code: LUPQUC
Location: 3rd floor conference room by the purple elevators and virtually on WebEx
Directions: If you are having trouble accessing WebEx, please contact Cassy Sims at cas206@duke.edu
Streaming: Via WebEx. Link: https://dukemed.webex.com/dukemed/j.php?MTID=m57511734eb4f3e4f0423f94de8a7eb34
Meeting Number/Access Code: 120 459 7417 (you will not need this if you use link above)
Call-in number: 1-650-479-3207
Add to calendar:
Session date:
07/20/2021 - 8:00am to 9:00am EDT
Room Number:
WebEx (or 3rd floor conference room, Duke South, purple zone -- for faculty & fellows only)
Speaker Name:
Dr. David Pisetsky